Edoxaban: A Novel Factor Xa Inhibitor for the Management of Non-valvular Atrial Fibrillation and Venous Thromboembolism
This article provides an overview of the safety and efficacy along with the advantages and disadvantages of edoxaban.
Source: Cardiology in Review - Category: Cardiology Tags: New Therapy Update Source Type: research
More News: Atrial Fibrillation | Bleeding | Cardiology | Coumadin | Heart | Stroke | Thrombosis | Vitamins | Warfarin